経カテーテル僧帽弁移植術（TMVI）市場：セグメント別規模、シェア、法規制、償還、手技、2033年までの予測

経カテーテル的僧帽弁移植術（TMVI）は、大動脈瘤や解離の治療に使用されます。大動脈瘤は胸部大動脈（胸部大動脈瘤-TAA）と腹部大動脈（腹部大動脈瘤-AAA）の両方に発生する可能性があります。大動脈瘤は、大動脈の壁が弱くなり、大きく膨らんで発生します。

当レポートは、世界の経カテーテル僧帽弁移植術（TMVI）市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、地域、国別の動向などを提供しています。

目次

現在上市されている経カテーテル僧帽弁移植術（TMVI）と競合情勢

• 主要な業界動向の洞察
• 経カテーテル僧帽弁移植術（TMVI）のセグメント別総市場収益と2015年～2033年の市場展望
• セグメント別の手技総数、台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 経カテーテル僧帽弁移植術（TMVI）市場のSWOT分析
• 経カテーテル僧帽弁移植術（TMVI）市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

Transcatheter Mitral Valve Implantation (TMVI) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Transcatheter Mitral Valve Implantation (TMVI) are used to treat aortic aneurysms and dissections. Aortic aneurysms can occur in both the thoracic aorta (Thoracic Aortic Aneurysms - TAA) and abdominal aorta (Abdominal Aortic Aneurysms - AAA). Aortic aneurysms occur when the walls of the aorta weaken, resulting in a large swelling and weakening of the aortic wall.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Transcatheter Mitral Valve Implantation (TMVI) market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Transcatheter Mitral Valve Implantation (TMVI) market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Transcatheter Mitral Valve Implantation (TMVI) market.
• Competitive dynamics insights and trends provided Transcatheter Mitral Valve Implantation (TMVI) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Transcatheter Mitral Valve Implantation (TMVI) marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Transcatheter Mitral Valve Implantation (TMVI) market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Mitral Valve Implantation (TMVI) market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Transcatheter Mitral Valve Implantation (TMVI) market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.